Nutriband receives Chinese patent for AVERSA abuse-deterrent transdermal system

NutriBand Inc.

CNIPA fully issued Patent No. ZL 202211158031 for 'Abuse and Misuse Deterrent Transdermal System' related to AVERSA technology.
Patent covers taste aversion to prevent abuse of opioid patches; previously allowed in September 2024.
AVERSA IP portfolio now includes granted patents in US, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
Lead product under development is an abuse-deterrent fentanyl patch incorporating AVERSA technology.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.